The voice intraction technology provider, which counts a host of corporates among its investors, will get a Nasdaq listing through the transaction.

The DRx Capital-backed healthcare database developer scored fresh capital to increase its overall funding to over $190m.

The neuromodulation-focused Stanford spinout increased its overall funding to $145m in a round led by Ascension Ventures.

The neuromodulation device maker increased its overall funding to $145m in a round led by Ascension Ventures.

Citi has exited neobanking software developer Digit and real estate analytics provider Reonomy in acquisitions each sized at over $200m.

Koch Disruptive Technologies returned for a round valuing the consumer finance provider at $6bn pre-money.

Japan Post Capital returned to participate in the fresh produce delivery service’s latest close at a $1.2bn valuation, after two series E tranches disclosed recently.

Catapult Capital Partners will invest in consumer-minded startups, having already backed Simply Protein and Target 100 and secured an exit through the TSX-listed Flow Water.

The Barracuda Networks-backed expense management platform developer added $39m to an offering in which it had floated at the top of its range.

Oncology therapy developer Recludix Pharma raised $60m in an Access Biotechnology-backed round while Stripe took part in digital payment technology developer Imprint's $38m series A.